Research & Clinical Trials
- One-year exploratory study to evaluate the efficacy and safety of belimumab for normalization of alloantibody levels in sensitized patients awaiting kidney transplantation.
-
- Investigator: Ali Naji, MD, PhD
- Changes in skeletal microarchitecture following renal transplantation
-
- Investigators: Simin Goral, MD and Mary Leonard, MD
- Genetic determinants of kidney transplant outcomes
-
- Investigator: Sylvia E. Rosas, MD
- Sponsored by: National Institutes of Health
- Vascular calcification in kidney transplant recipients
-
- Investigator: Sylvia E. Rosas, MD
- Sponsored by: American Heart Association
- Clinical trials in organ transplantation (CTOT)
-
- Investigator: Abraham Shaked, MD, PhD
- Sponsored by: National Institutes of Health
- A phase IV, randomized, open-label, comparative, single-center study to assess gastrointestinal adverse event outcomes of de novo African American kidney transplant recipients treated with Prograf® (tacrolimus) /CellCept® (mycophenolate mofetil)/corticosteroids versus Prograf (tacrolimus)/Myfortic® (enteric-coated mycophenolate sodium)/corticosteroids
-
- Investigator: Roy Bloom, MD
For more information about clinical trials at the Penn Transplant Institute, see Research & Clinical Trials.